Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
eMurmur is a private digital health and medical device software company focused on AI-enabled digital auscultation for heart, lung, and bowel assessment. The company provides a hardware-agnostic software platform that works with multiple digital stethoscopes across mobile, web, telehealth, and partner-integrated workflows. Its products include FDA-cleared and CE-marked heart murmur detection and broader auscultation analysis tools used for screening, monitoring, diagnosis support, remote exams, and education. eMurmur also powers educational applications such as the Littmann Learning app and positions itself as an AI layer for stethoscope makers, telehealth providers, and home-health solutions. The business is best characterized as a commercial-stage medtech/software platform company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on eMurmur.